• UnitedHealth Group (NYSE: UNH) reported Q3 2026 adjusted earnings of $4.69 per share, beating the $4.14 consensus, and raised its full-year adjusted EPS guidance to at least $20.50.
• The medical care ratio improved to 88.4% from 89.9% a year earlier, supporting stronger profitability despite continued pressure from Medicare Advantage costs and declining membership.
• Wall Street’s average 12-month price target stands at $480.60, suggesting approximately 25% upside from early October 13 trading levels. Management indicated that 2027 earnings growth could exceed current analyst expectations.

UnitedHealth Group (NYSE: UNH) shares advanced following its October 13, 2026, earnings release as the largest U.S. private health…